Modified oligonucleotides as therapeutic and diagnostic agents
References (58)
- et al.
The functionalization of oligonucleotides via phosphoramidite derivatives. Tetrahedron report no. 329
Tetrahedron
(1993) - et al.
Synthesis of oligodeoxynucleoside methylphosphonothioates
Bioorg Med Chem Lett
(1993) - et al.
Design and synthesis of deoxynucleic guanidine: a polycation analogue of DNA
Proc Natl Acad Sci USA
(1994) - et al.
Synthesis of an oxyamide linked nucleotide dimer and incorporation into antisense oligonucleotide sequences
J Chem Soc Chem Commun
(1994) - et al.
Synthesis and hybridization studies of urea and carbamate linked thymidine dimers incorporated into oligodeoxynucleosides
Bioorg Med Chem Lett
(1994) - et al.
Synthesis of di-, tri-, and tetrameric building blocks with novel carbamate internucleoside linkages and their incorporation into oligonucleotides
Bioorg Med Chem Lett
(1994) - et al.
The synthesis of modified achiral internucleoside linkages: -NHCH2CH2- linked oligonucleosides
Tetrahedron Lett
(1993) - et al.
Comparison of rigid and flexible backbones in antisense oligonucleotides
Bioorg Med Chem Lett
(1994) - et al.
Synthesis of sulfonate-linked DNA
J Org Chem
(1994) - et al.
Oligodeoxynucleotides containing 3'-allylether, 3'-allysulfide and their saturated derivatives as phosphate mimics
Tetrahedron Lett
(1994)
Structure-activity studies of the binding of modified peptide nucleic acids (PNAS) to DNA
J Am Chem Soc
(1994)
Stereospecific bio-reversibility of dinucleoside S-alkyl phosphorothiolates to dinucleoside phosphorothioates
Bioorg Med Chem Lett
(1994)
Synthesis of 3'-O-(w-aminoalkyloxymethyl)thymidine 5'-triphosphates, terminators of DNA synthesis that enable 3'-labeling
J Chem Soc Perkin Trans 1
(1994)
Synthesis and complementary complex formation properties of oligonucleotides covalently linked to new stabilizing agents
Tetrahedron
(1994)
Bi-functional labeling of DNA with tris(2-aminoethyl)amine-derived novel fluorescent agent
Bioorg Med Chem Lett
(1993)
Biodistribution and metabolism of internally 3H-labeled oligonucleotides. I. Comparison of a phosphodiester and a phosphorothioate
Mol Pharmacol
(1994)
(1993)
(1993)
(1993)
Pharmacokinetics of an antisense phosphorothioate oligodeoxynucleotide against Rev from human immunodeficiency virus type 1 in the adult male rat following single injections and continuous infusion
Antisense Res Dev
(1994)
Disposition of the 14C-labeled phosphorothioate oligonucleotide ISIS 2105 after intravenous administration to rats
J Pharmacol Exp Ther
(1993)
Pharmacokinetics, biodistribution and stability of capped oligodeoxynucleotide phosphorothioates in mice
Antisense Res Dev
(1993)
Antisense oligonucleotides as therapeutic agents — is the bullet really magical?
Science
(1993)
Cardiovascular effects of a phosphorothioate oligonucleotide with sequence antisense to p53 in the conscious rhesus monkey
Pharmacol Commun
(1993)
Complement activation and hemodynamic changes following intravenous administration of phosphorothioate oligonucleotides in monkey
Antisense Res Dev
(1994)
Systematic administration of a phosphorothioate oligonucleotide with a sequence complementary to p53 for acute myelogenous leukemia and myelodysplastic syndrome: initial results of a phase I trial
Antisense Res Dev
(1993)
Antisense oligonucleotide phosphorothioate complementary to gag mRNA blocks HIV-1 replication in human peripheral blood cells
Proc Natl Acad Sci USA
(1994)
Antiviral activity of a phosphorothioate oligonucleotide complementary to RNA of the human cytomegalovirus major immediately-early region
Antimicrob Agents Chemother
(1993)
Cited by (0)
Copyright © 1995 Published by Elsevier Ltd.